Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 29, 2022 16:05 ET | Source: Codexis, Inc.

Codexis Provides Update on Prioritized Corporate Strategy

REDWOOD CITY, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced an update on the Company’s ongoing plan to prioritize its...
November 16, 2022 16:05 ET | Source: Codexis, Inc.

Codexis to Participate in Piper Sandler 34th Annual Healthcare Conference

REDWOOD CITY, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management...
November 08, 2022 16:05 ET | Source: Codexis, Inc.

Codexis to Participate in Upcoming Healthcare Conferences

REDWOOD CITY, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management...
November 03, 2022 16:05 ET | Source: Codexis, Inc.

Codexis Reports Third Quarter 2022 Financial Results

REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced financial...
November 01, 2022 08:00 ET | Source: Codexis, Inc.

Codexis Announces Appointment of Margaret Fitzgerald as Chief Legal Officer and General Counsel

REDWOOD CITY, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the appointment...
October 20, 2022 16:05 ET | Source: Codexis, Inc.

Codexis to Report Third Quarter 2022 Financial Results on November 3

REDWOOD CITY, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that it will...
October 03, 2022 08:00 ET | Source: Codexis, Inc.

Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors

REDWOOD CITY, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the appointment...
October 03, 2022 08:00 ET | Source: Codexis, Inc.

Codexis Announces Appointment of Kevin Norrett as Chief Operating Officer

REDWOOD CITY, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the appointment...
September 14, 2022 16:05 ET | Source: Codexis, Inc.

Codexis’ 2022 Protein Engineering Forum Showcases Recent Industry Success and Emerging Innovations in the Field

REDWOOD CITY, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the recent...
August 04, 2022 16:05 ET | Source: Codexis, Inc.

Codexis Reports Second Quarter 2022 Financial Results

Total Revenue up 51% and Product Revenue up 135% YOY 2022 Total Revenue Guidance of $135M-$141M, Including Product Revenues of $112M-$118M REDWOOD CITY, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) --...